Concepedia

Shanliang Zheng

SZ

Statistics

Publications

12

Citations

474

H-Index

12

Active since

2019

Affiliations

Harbin Institute of Technology(Current)

Third Affiliated Hospital of Harbin Medical University

Harbin Medical University

Heilongjiang Institute of Technology

BGI Group (China)

Shanliang Zheng is an author at Harbin Institute of Technology specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2019–2024

12

Publications

12

Photothermal conversion-coordinated Fenton-like and photocatalytic reactions of Cu2-xSe-Au Janus nanoparticles for tri-combination antitumor therapy

Yuanlin Wang, Zhenglin Li, Ying Hu et al. · Biomaterials · 2020 · 119 citations

, , +17

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation

Wenxin Zhang, Junren Dai, Guixue Hou et al. · Molecular Cell · 2023 · 104 citations · Full text

, , +7

miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways

Xue Feng, Naimeng Yan, Weibin Sun et al. · Cell Death Discovery · 2019 · 51 citations · Full text

, , +17

iASPP suppresses Gp78-mediated TMCO1 degradation to maintain Ca <sup>2+</sup> homeostasis and control tumor growth and drug resistance

Shanliang Zheng, Dong Zhao, Guixue Hou et al. · Proceedings of the National Academy of Sciences · 2022 · 43 citations · Full text

, , +17

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity

Qingyu Lin, Tong Liu, Xingwen Wang et al. · Journal of Clinical Investigation · 2023 · 31 citations · Full text

, , +17

1–5 of 12